Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (116)
2025 (1325)
2024 (1331)
2023 (1277)
2022 (1392)
2021 (1425)
2020 (1224)
2019 (1083)
2018 (1143)
2017 (1036)
2016 (936)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (14812)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Pokrovskaja Tamm K
JSON
CSV
XLSX
TXT
Family name
Pokrovskaja Tamm
Given name
Katja
Initials
K
ORCID
ORCID
0000-0001-6359-1256
Affiliations
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
5 publications
PubMed
DOI
Crossref
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.
Yu Y
, Bogdan M, Noman MZ, ..., De Milito A,
Janji B
Mol Oncol
18
(8) 1904-1922 [2024-08-00; online 2024-03-20]
PubMed
DOI
Crossref
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children.
Stratmann S
,
Vesterlund M
,
Umer HM
, ...,
Lehtiö J
,
Holmfeldt L
Leukemia
37
(3) 550-559 [2023-03-00; online 2022-12-26]
PubMed
DOI
Crossref
Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines.
Leo IR
,
Aswad L
,
Stahl M
, ...,
Vesterlund M
,
Jafari R
Nat Commun
13
(1) 1691 [2022-03-30; online 2022-03-30]
PubMed
DOI
Crossref
Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death.
Busker S
, Qian W, Haraldsson M, ...,
Tamm KP
,
Page BDG
Sci Adv
6
(12) eaax7945 [2020-03-00; online 2020-03-20]
PubMed
DOI
Crossref
Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment.
Dyczynski M
, Vesterlund M, Björklund AC, ...,
Tamm KP
,
Nilsson R
Cell Death Dis
9
(9) 846 [2018-08-28; online 2018-08-28]
SciLifeLab Data Centre
Publications
9.5.1